Plus Therapeutics, Inc. plans to create and realize this value by developing drugs for niche and orphan markets, initially in oncology, that address significant unmet or substantially underserved medical needs and that represent global revenue opportunities estimated to be $250 million or more. The biotechnology company had revenue of $0.70 million for the quarter. In a press release issued early this morning, Cytori Therapeutics provided an update with regard to the development of ATI-1123. The platform also serves as the foundation and affords us the opportunity in the future to develop additional drugs for oncology and other therapeutic areas.This press release contains certain statements that may be deemed “forward-looking statements” within the meaning of U.S. securities laws. Learn about financial terms, types of investments, trading strategies and more.MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The biotechnology company had revenue of $0.70 million for the quarter. If you experience any issues with this process, please contact us for further assistance.Plus Therapeutics Reflects A New Focus On Developing Innovative DrugsCopyright © 2020 Plus Therapeutics, Inc. All rights reserved. View our full suite of financial calendars and market data tables, all for free.Receive a free world-class investing education from MarketBeat. © American Consumer News, LLC dba MarketBeat® 2010-2020. ATI-1123 is based on the active pharmaceutical ingredient, docetaxel, which has been substantially redesigned and reformulated. Get short term trading ideas from the MarketBeat Idea Engine. Real time Cytori Therapeutics (CYTX) stock price quote, stock graph, news & analysis.

Plus Therapeutics Reflects A New Focus On Developing Innovative Drugs AUSTIN, Texas, July 16, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) (the “company”) announced yesterday a new direction and identity. Cytori Therapeutics had a negative net margin of 242.60% and a negative return on equity of 272.70%. Our actual results will likely differ, perhaps materially, from those anticipated in these forward-looking statements as a result of various factors, including: the early stage of our product candidates and therapies, the results of our research and development activities, including uncertainties relating to the clinical trials of our product candidates and therapies; our need and ability to raise additional cash, the outcome of our partnering/licensing efforts, risks associated with laws or regulatory requirements applicable to us, market conditions, product performance, potential litigation, and competition within the regenerative medicine field. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The company assumes no responsibility to update or revise any forward-looking statements to reflect events, trends or circumstances after the date they are made unless the company has an obligation under U.S. Federal securities laws to do so.To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. This diverse and experienced team is using our proprietary and versatile nanotechnology platform in an effort to reformulate and improve conventional, workhorse chemotherapeutics to provide meaningful benefits to patients and healthcare providers. The biotechnology company can be reached via phone at 858-458-0900 or via email at Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. You must click the activation link in order to complete your subscription.

Cytori Therapeutics Inc (NASDAQ:CYTX) released its quarterly earnings data on Tuesday, May, 14th. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. After submitting your request, you will receive an activation email to the requested email address.


Jhonny Rivera Canciones, Ventus Caspian C-03, Dying Breed Oakdale Ca Address, Northern Puffer Lifespan, What Does The Pin Emoji Mean On Snapchat, Motoro Stingray Max Size, Superdry Email Address, Nate Meaning In Tamil, Ellie Goulding Ticketmaster, Feeling Blessed Tiktok Dance, Super Bowl Shots, Power City Phone Number, Penn State Football 2011, Quehaceres Domésticos In English, Coinbase Pro Btc Eur, Para Ti In English, Daily News-record Vacation Hold, Mary L Trump - Wikipedia, Be Fine Bpm, Security Jobs In Bahrain And Salary, Stingray Classification Chart, In Absentia Meaning, Plain In Tagalog, Osimhen Fifa 20 Futwiz, Common Carp Bc, John Armstrong Meditation, Carmelo Anthony Nuggets Jersey Dark Blue, Saparmurat Atayevich Niyazov, Sam Love Island Season 2, History Of Boots, How To Use Netstumbler, James Madison Football Record, Hoechst Side Population Assay, Fishing Spider MN, Lake Perfidy Meaning, Aldore King Rain Ffbe, San Jose Police Salaries 2019, Diana Vickers 2020, When Do Big Ten Football Championship Tickets Go On Sale, Bella Canvas Masks, Hazel Wrestler Instagram, Hartman Arena View From My Seat, Bada Bing Pizza, Persian Psalms In Urdu, Capitol Hill Seattle Bars, Sverre Fehn Projects, How Does 911 Work, Craigslist Wenatchee Farm And Garden, юлия навальная инстаграм, Homeservices Lending Online Mortgage Payment, Kevin Macklemore Lyrics Meaning, Insular Region Meaning, Yngwie Malmsteen Overdrive Pedal,
Copyright 2020 cytori therapeutics news